UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
July 20, 2004
(Date of report)
CARACO PHARMACEUTICAL LABORATORIES, LTD.
--------------------------------------------------------
(Exact name of registrant as specified in its charter)
Michigan 0-24676 38-2505723
------------------------------------- ---------------------------------- ----------------------------------
(State or other jurisdiction of (Commission file number) (I.R.S. employer identification
incorporation) no.)
1150 Elijah McCoy Drive, Detroit, Michigan 48202
--------------------------------------------------------
(Address of principal executive offices)
(313) 871-8400
--------------------------------------------------------
(Registrant's telephone number, including area code)
Not Applicable
--------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
c) Exhibits.
Exhibit No. Description
99.1 Press Release of Caraco Pharmaceutical Laboratories,
Ltd., dated July 20, 2004 announcing second quarter
of 2004 results of operations.
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On July 20, 2004, registrant announced its results of operations for
the quarter ended June 30, 2004, as set forth in the press release included as
Exhibit 99.1 hereto, which is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
CARACO PHARMACEUTICAL LABORATORIES, LTD.
Date: July 20, 2004 By: /s/ Jitendra N. Doshi
-----------------------------
Jitendra N. Doshi
Chief Executive Officer
EXHIBIT INDEX
99.1 Press Release of Caraco Pharmaceutical Laboratories, Ltd.,
dated July 20, 2004 announcing second quarter of 2004 results
of operations.
2